Skip to main content

Research News

  • A blood pressure drug may make a type of lung cancer treatment more effective, suggests a new study.The early-stage research, conducted on human cells in the lab and on mice, was led by scientists from Imperial College London and Fudan University in China, and is published in the journal Cell Discovery.

  • Sahajanand Medical Technologies Pvt. Ltd. (SMT), India’s largest manufacturer of cardiovascular medical stents today announced the opening of its new Research & Development Centre in Galway City, Ireland. SMT aims to attract global talent through this new facility in Ireland to diversify its product portfolio. The company has significant investment plans to develop this R&D Centre.

  • Incidence and mortality rates for most cancers are increasing in emerging countries, mostly due to the adoption of unhealthy Western lifestyles such as smoking, physical inactivity, and diet. BCC Research reveals in its new report that the hematological cancer drug sector is leading growth in the global market for hematology drugs and diagnostics.

  • A new study of classical Chinese medical texts identifies references to age-related memory impairment similar to modern-day Alzheimer's disease, and to several plant-based ingredients used centuries ago -- and still in use today -- to treat memory impairment. Experimental studies of five of these traditional Chinese medicines suggest that they have biological activity relevant to Alzheimer's disease, according to an article in The Journal of Alternative and Complementary Medicine, a peer-reviewed publication from Mary Ann Liebert, Inc.

  • Discovery of a novel, advanced technique to identify the rare cells where human immunodeficiency virus (HIV) hides in patients taking antiretroviral therapy (ART). This is an important step forward in the search for a HIV/AIDS cure.

  • Tiny, star-shaped molecules are effective at killing bacteria that can no longer be killed by current antibiotics, new research shows.

  • Researchers with the Harold C. Simmons Comprehensive Cancer Center successfully developed a synthetic polymer that can transport a drug into lung cancer cells without going inside of normal lung cells.

    Since conventional chemo drugs indiscriminately kill all rapidly dividing cells to halt the growth of cancer, these selective nanoparticles could decrease side effects by reducing drug accumulation in normal cells.

Subscribe to Research News